Pfizer looks to sell stake in pandemic vaccine partner BioNTech
Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech, a remnant from one of the pandemic’s most lucrative collaborations. The US drugmaker is offering about…










